F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53%
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Gross Margin
Fluidigm Corp

48.6%
Current
46%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
48.6%
=
Gross Profit
75.7m
/
Revenue
155.9m

Gross Margin Across Competitors

Country US
Market Cap 703.6m EUR
Gross Margin
49%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.4B USD
Gross Margin
41%
Country US
Market Cap 165.4B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Country US
Market Cap 35.9B USD
Gross Margin
35%
Country US
Market Cap 26.8B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 164.4B CNY
Gross Margin
40%
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
703.6m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.67 EUR
Overvaluation 65%
Intrinsic Value
Price
F

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
48.6%
=
Gross Profit
75.7m
/
Revenue
155.9m
What is the Gross Margin of Fluidigm Corp?

Based on Fluidigm Corp's most recent financial statements, the company has Gross Margin of 48.6%.